Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86


Prostratin: An Overview.

Miana GA, Riaz M, Shahzad-Ul-Hussan S, Paracha RZ, Paracha UZ.

Mini Rev Med Chem. 2015 May 11. [Epub ahead of print]


The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.

Shen X, Xiong GL, Jing Y, Xiao H, Cui Y, Zhang YF, Shan YJ, Xing S, Yang M, Liu XL, Dong B, Wang LS, Luo QL, Yu ZY, Cong YW.

Cancer Lett. 2015 Jan 28;356(2 Pt B):686-96. doi: 10.1016/j.canlet.2014.10.018. Epub 2014 Oct 22.


Production of bioactive diterpenoids in the euphorbiaceae depends on evolutionarily conserved gene clusters.

King AJ, Brown GD, Gilday AD, Larson TR, Graham IA.

Plant Cell. 2014 Aug;26(8):3286-98. doi: 10.1105/tpc.114.129668. Epub 2014 Aug 29.


Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.

Lan J, Yang K, Byrd D, Hu N, Amet T, Shepherd N, Desai M, Gao J, Gupta S, Sun Y, Yu Q.

J Immunol. 2014 Oct 1;193(7):3577-89. doi: 10.4049/jimmunol.1303030. Epub 2014 Aug 22.


Protein kinase D3 is essential for prostratin-activated transcription of integrated HIV-1 provirus promoter via NF-κB signaling pathway.

Wang H, Zhu X, Zhu Y, Liu J, Hu X, Wang Y, Peng S, Chen Y, Chen R, Ding F, Liu R.

Biomed Res Int. 2014;2014:968027. doi: 10.1155/2014/968027. Epub 2014 Jul 21.


Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.

Abreu CM, Price SL, Shirk EN, Cunha RD, Pianowski LF, Clements JE, Tanuri A, Gama L.

PLoS One. 2014 May 14;9(5):e97257. doi: 10.1371/journal.pone.0097257. eCollection 2014.


As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.

Wang P, Qu X, Wang X, Liu L, Zhu X, Zeng H, Zhu H.

Antiviral Res. 2013 Oct 25. pii: S0166-3542(13)00300-8. doi: 10.1016/j.antiviral.2013.10.010. [Epub ahead of print]


As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.

Wang P, Qu X, Wang X, Liu L, Zhu X, Zeng H, Zhu H.

Antiviral Res. 2013 Dec;100(3):688-97.


Emerging strategies to deplete the HIV reservoir.

Archin NM, Margolis DM.

Curr Opin Infect Dis. 2014 Feb;27(1):29-35. doi: 10.1097/QCO.0000000000000026. Review.


Calcium/calcineurin synergizes with prostratin to promote NF-κB dependent activation of latent HIV.

Chan JK, Bhattacharyya D, Lassen KG, Ruelas D, Greene WC.

PLoS One. 2013 Oct 30;8(10):e77749. doi: 10.1371/journal.pone.0077749. eCollection 2013.


Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo.

Beans EJ, Fournogerakis D, Gauntlett C, Heumann LV, Kramer R, Marsden MD, Murray D, Chun TW, Zack JA, Wender PA.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11698-703. doi: 10.1073/pnas.1302634110. Epub 2013 Jun 28.


[Chemical constituents from Daphne acutiloba].

Huang SZ, Ma QY, Liu YQ, Zhou J, Zhao YX.

Zhongguo Zhong Yao Za Zhi. 2013 Jan;38(1):64-9. Chinese.


Prostratin and 12-O-tetradecanoylphorbol 13-acetate are potent and selective inhibitors of Chikungunya virus replication.

Bourjot M, Delang L, Nguyen VH, Neyts J, Guéritte F, Leyssen P, Litaudon M.

J Nat Prod. 2012 Dec 28;75(12):2183-7. doi: 10.1021/np300637t. Epub 2012 Dec 7.


Prostratin exhibits both replication enhancing and inhibiting effects on FIV infection of feline CD4+ T-cells.

Chan CN, McMonagle EL, Hosie MJ, Willett BJ.

Virus Res. 2013 Jan;171(1):121-8. doi: 10.1016/j.virusres.2012.11.004. Epub 2012 Nov 28.


Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB.

Ying H, Zhang Y, Zhou X, Qu X, Wang P, Liu S, Lu D, Zhu H.

PLoS One. 2012;7(11):e48832. doi: 10.1371/journal.pone.0048832. Epub 2012 Nov 15.


Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines.

Qu X, Ying H, Wang X, Kong C, Zhou X, Wang P, Zhu H.

Curr HIV Res. 2013 Jan;11(1):24-9.


The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.

Li Z, Guo J, Wu Y, Zhou Q.

Nucleic Acids Res. 2013 Jan 7;41(1):277-87. doi: 10.1093/nar/gks976. Epub 2012 Oct 18.


Reactivation of latent HIV-1 by inhibition of BRD4.

Zhu J, Gaiha GD, John SP, Pertel T, Chin CR, Gao G, Qu H, Walker BD, Elledge SJ, Brass AL.

Cell Rep. 2012 Oct 25;2(4):807-16. doi: 10.1016/j.celrep.2012.09.008. Epub 2012 Oct 4.


Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro.

DeChristopher BA, Loy BA, Marsden MD, Schrier AJ, Zack JA, Wender PA.

Nat Chem. 2012 Sep;4(9):705-10. doi: 10.1038/nchem.1395. Epub 2012 Jul 15.


Pharmaceutical potential of phorbol esters from Jatropha curcas oil.

Devappa RK, Malakar CC, Makkar HP, Becker K.

Nat Prod Res. 2013;27(16):1459-62. doi: 10.1080/14786419.2012.716057. Epub 2012 Aug 22.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk